Results 41 to 50 of about 306 (101)

Statement of Argentine pediatric endocrinologists on growth hormone interchangeability [PDF]

, 2019
Growth hormone (GH), just like vaccines, antibodies, and other hormones, is a biological medicinal product (BMP); therefore, it is produced by a complex mechanism that is specific to each (trademark) product.
Alonso, Guillermo, Balbi, Viviana, Bazán de Casella, María Cristina del Valle, Belgorosky, Alicia, Bergadá, Ignacio, Brunetto, Oscar, Cassinelli, Hamilton Raul, Ciaccio, Marta Graciela Cristina, Keselman, Ana Claudia, Miras, Mirta Beatriz, Morín, Analía   +10 more
core   +1 more source

Jacobsen Syndrome: A Case Report With Olfactory Bulb Agenesis, Severe Endocrinopathy, and Neurodevelopmental Delay

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Jacobsen syndrome is a rare 11q deletion disorder with multisystem involvement. This case highlights a complex unbalanced 11;15 translocation, olfactory bulb agenesis, extensive white matter abnormalities, and severe endocrinopathies, emphasizing the need for comprehensive genetic and neuroimaging evaluations.
Sajjad Ghanim Al‐Badri, Aditya Duhan, Rania H. Al‐Taie, Muntadher Yousif Hasan Al Gehadi, Ibrahim Khalil   +4 more
wiley   +1 more source

A Phase 2 Study of PEGylated Recombinant Human Growth Hormone for 52 Weeks in Short Children Born Small for Gestational Age in China

Clinical Endocrinology, Volume 102, Issue 2, Page 136-146, February 2025.
ABSTRACT Objective Children born small for gestational age (SGA) are at increased risk of health issues. This study evaluated the efficacy, safety and optimal dose of PEGylated‐recombinant human growth hormone (PEG‐rhGH) in these children. Design In this multicentre, randomised, open‐label, Phase 2 trial conducted at nine clinical sites in China ...
Xiaoping Luo, Ling Hou, Yan Zhong, Sha Zhao, Xiaobo Chen, Qian Dong, Hongwei Du, Honghua Lu, Yu Yang, Xian Wu, Feihong Luo, Ruoqian Chen, Zhuangjian Xu, Yaping Ma, Wenhui Song, Mei Feng, Xuefan Gu, Wenjuan Qiu   +17 more
wiley   +1 more source

What is the prevalence of anabolic‐androgenic steroid use among women? A systematic review

Addiction, Volume 119, Issue 12, Page 2088-2100, December 2024.
Abstract Background and aim Evidence suggests there has been an increase in anabolic‐androgenic steroid (AAS) use among women, driven by the evolving landscape of women's participation in sport. However, the extent of use is unknown. This systematic review aimed to estimate the prevalence of women's AAS use.
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, April Henning, Eric H. Y. Lau, Matthew Dunn   +5 more
wiley   +1 more source

Cancer treatment with biosimilar drugs: A review

Cancer Innovation, Volume 3, Issue 2, April 2024.
With crucial mutational categories, biosimilar drug prototypes, and clinical practices including blood and liquid biopsy, cell therapy, gene therapy, recombinant therapeutic proteins, and tailored pharmaceuticals, it aids in targeting certain organs.
Shilpa Malakar, Emmanuel Nuah Gontor, Moses Y. Dugbaye, Kamal Shah, Sakshi Sinha, Priya Sutaoney, Nagendra Singh Chauhan   +6 more
wiley   +1 more source

Biosimilars in Belgium: a proposal for a more competitive market [PDF]

, 2020
More than ten years after the first biosimilars were authorized for use in the European Union, Belgium still experiences limited competition from biosimilars, as exemplified by low market shares. Achieving high biosimilar market shares is not necessarily
Huys, I. (Isabelle), Moorkens, E. (Evelien), Vulto, A.G. (Arnold)   +2 more
core   +3 more sources

Recommendations for treatment with recombinant human growth hormone in pediatric patients in Colombia [PDF]

, 2020
En Colombia, actualmente no existen parámetros claros para el diagnóstico de pacientes con talla baja, ni sobre el tratamiento de esta población con hormona de crecimiento recombinante humana (somatropina), lo cual se ve favorecido por la diversidad de ...
Acevedo Peña, Juan, Angulo Mosquera, Mario, Arango Villa, Álvaro, Argente Oliver, Jesús, Bareño Campos, Diana, Barrero Garzón, Liliana Isabel, Castillo Gutiérrez, Ana, Castro Tobón, Andrea, Correa Saldarriaga, Johana, Céspedes Salazar, Camila, Durán Ventura, Paola, Escobar, Oscar, Fama Pereira, Marcela, Fernández Hernández, Mónica, Forero Ronderos, Catalina, Gil Ochoa, Nayive, González López, Vladimir, González Patiño, Angélica, Gómez Gómez, Olga, Heredia Ramírez, Claudia, Laverde Gaona, Luis, Lema Izquierdo, Adriana, Llano Linares, Juan, Low Padilla, Eduardo, López Miranda, Ángelo, López Rivera, Juan, Manrique Torres, Giovana, Matallana Rhoadesa, Audrey, Mejía Gaviria, Natalia, Mejía Zapata, Liliana, Mendivelso Duarte, Fredy, Monroy Espejo, Jennyfer, Muñoz Osorio, Samantha, Pedraza Flechas, Paola, Pinzon Serrano, Estefania, Páez Espitia, Martha, Roa Rodríguez, Sandra, Rojas Barrera, Carolina, Romero Acosta, Dora, Ruíz Amaya, Diego, Suarez Cárdenas, María, Toro Ramos, Martin, Urueña Zuccardi, María, Vargas Rodríguez, Johanna, Velásquez Rodríguez, Ana, Yomayusa González, Nancy   +45 more
core   +3 more sources

Prospects and Trends in the Brazilian Market for Biologically Sourced Products [PDF]

, 2012
The aim of this paper was to select the most interesting Brazilian biopharmaceuticals, with the best market opportunity for production. The biopharmaceuticals filgrastim, infliximab, somatropin, imiglucerase, betainterferon and factor VIII were selected ...
Borschiver, Suzana, Madeira, Luciana da Silva, Pereira Jr, Nei   +2 more
core   +3 more sources

Letters to the Editor

, 2014
Canadian Journal of Gastroenterology and Hepatology, Volume 28, Issue 8, Page 452-454, 2014.
Miklos Sebeszta, Alex Kudrin
wiley   +1 more source

Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics

, 2013
Canadian Journal of Gastroenterology and Hepatology, Volume 27, Issue 10, Page 567-571, 2013.
Shane M Devlin, Brian Bressler, Charles N Bernstein, Richard N Fedorak, Alain Bitton, Harminder Singh, Brian G Feagan   +6 more
wiley   +1 more source